They are designed and used for the chronic disease of obesity." Lars Fruergaard Jrgensen, the CEO of Novo Nordisk which makes Ozempic and Wegovy, has previously blamed insurers and middlemen for the high prices of the drugs
For them, she says, the true cost extends well beyond the $50 copay, adding monthly premiums and possibly late enrollment penalties
Unknown Effectiveness at Sub-Therapeutic Doses: Our understanding of tirzepatides effectiveness is based on evidence from trials using therapeutic doses of 2mg or more
Cui, G., Xu, W
Patients should rotate injection sites to reduce the risk of injection-site reactions such as lumps, thickening or dimpling of the skin
PubMed , For your reference: For your reference: For your reference: 19 Leslie, Stephen W., et al